Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity
Recruiting
N/A
Interventional Study
Wilson Disease
D-Penicillamine
Effect of D-penicilline on Cutaneous Elastity of Wilson's Patient
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 12 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 120 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Wilson's disease is a genetic disorder, resulting from an anomaly present on the ATP7B gene located on chromosome 13, causing a progressive accumulation of copper in various organs such as the liver, nervous system and cornea, leading to various hepatic and neurological disorders and a systemic evolution.
Currently, the first-line treatment for this disease is D-Penicillamine, which acts by chela…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Diseased patients :
* Patient over 12 years old
* Patient with Wilson's disease confirmed by genetic analysis
* Patient followed up in the Wilson's Disease Reference Center for his care
* Patient treated with D-Penicillamine
* Patient with no other known elastic tissue patholog…
Contacts
Eduardo COUCHONNAL-BEDOYA, MD
(0)4 72 35 70 50
CONTACT